Literature DB >> 18855576

Novel diaryl or heterocyclic sulfonamides as antimitotic agents.

Laixing Hu1, Zhuo-rong Li, Jian-dong Jiang, David W Boykin.   

Abstract

The sulfonamides constitute an important class of drugs, which display a variety of activities including antibacterial, anti-carbonic anhydrase, diuretic, hypoglycemic and antithyroid effectiveness. A number of sulfonamides have been reported to be potent anticancer agents, which interact with a wide range of different cellular targets. Among these interesting sulfonamides, the diaryl or heterocyclic sulfonamides have recently emerged as an important class of antimitotic agents against different types of cancer, including multidrug resistant tumors. This review summarizes the recent advances of the diaryl or heterocyclic sulfonamides as novel antimitotic agents.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18855576     DOI: 10.2174/187152008785914806

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  2 in total

Review 1.  Indole-Based Tubulin Inhibitors: Binding Modes and SARs Investigations.

Authors:  Sheng Tang; Zhihui Zhou; Zhiyan Jiang; Wufu Zhu; Dan Qiao
Journal:  Molecules       Date:  2022-02-28       Impact factor: 4.411

2.  Methyl 2-bromo-3-(4-chloro-benzene-sulfonamido)-benzoate.

Authors:  Ahmad Z Ghafoor; Brian Chang; Christopher L King; Ray J Butcher; Amol A Kulkarni
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-01-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.